Converting glial cells to neurons, more effective CAR-Ts, and groundbreaking IDAs… What’s new in the advanced medicine field?

With all the hope and promise emanating from the cell and gene therapy field today, it’s easy to forget that we’ve had false dawns in the past.

We should be thrilled with the success of the approved CD-19 CAR-T therapies. But the field is still young, and we are only scratching the surface.

Here we discuss the problems of handling living, breathing cells in transit...

Sitting Down With Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, Perelman School of Medicine, University of Pennsylvania.

How are scientists seeking inspiration from plants in the fight against Alzheimer’s disease?

Why use a huge manufacturing facility when biological medicines can be made in a suitcase?

The stem cell industry needs to embrace bioprocess control systems to develop consistent, high quality, and commercially viable bioprocesses.

Sitting Down With… Stanley Crooke, Chairman of the Board & Chief Executive Officer at Ionis Pharmaceuticals.

Intensifying or simplifying your bioprocess can mean more product, shorter manufacturing times, or lower costs.